Letters to the Editor
Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy
I. Pirker1, A. Rubbert-Roth2, J. Von Kempis3, M. Fehr4, T. Neumann5
- Department of Rheumatology and Immunology, Cantonal Hospital St. Gallen, Switzerland. ian.pirker@kssg.ch
- Department of Rheumatology and Immunology, Cantonal Hospital St. Gallen, Switzerland.
- Department of Rheumatology and Immunology, Cantonal Hospital St. Gallen, Switzerland.
- Department of Medical Oncology and Haematology, Cantonal Hospital St. Gallen, Switzerland.
- Department of Rheumatology and Immunology, Cantonal Hospital St. Gallen, Switzerland.
CER12859
2020 Vol.38, N°3
PI 0573, PF 0574
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 31994482 [PubMed]
Received: 12/10/2019
Accepted : 09/12/2019
In Press: 28/01/2020
Published: 27/05/2020
